Chimerix Inc (NASDAQ:CMRX) does about 3.65M shares in volume on a normal day but saw 2114754 shares change hands in the recent trading day. The company now has a market cap of 252.72M USD. Its current market price is $2.81, marking a decrease of -3.44% compared to the previous close of $2.91. The 52 week high reached by this stock is $3.39 whilst the lowest price level in 52 weeks is $0.75.
Chimerix Inc (CMRX) has a 20-day trading average at $1.48 and the current price is -17.11% off the 52-week high compared with 274.67% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.14 and its 200-day simple moving average is $0.99. If we look at the stock’s price movements over the week, volatility stands at 13.66%, which decreases to 10.84% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 84.94 to suggest the stock is overbought.
The consensus objective for the share price is $8.40, suggesting that the stock has a potential upside of 66.55% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on May 23, 2023 when Robert W. Baird initiated the stock to “Outperform” and issued a price target of $7. Maxim Group initiated its price target at $20.
The current price level is 89.34%, 145.47%, and 183.09% away from its SMA20, SMA50, and SMA200 respectively, with the CMRX price moving below the 50-day SMA on current market day. Chimerix Inc (CMRX) stock is up 1.81% over the week and 226.78% over the past month. Its price is 191.95% year-to-date and 189.69% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.28 and -1.0 for whole year. Expected sales for next quarter are $100k, which analysts say will come at $937.8k for the current fiscal year and next year at $4.12M. In addition, estimates put the company’s current quarterly revenue at an average of $310.6k.
To reach the target analysts have set, the stock logically needs to grow 66.55 percent from here.
Outstanding shares total 89.94M with insiders holding 6.63% of the shares and institutional holders owning 45.90% of the company’s common stock. The company has a return on investment of -61.28% and return on equity of -48.59%. The beta has a value of 0.95. Price to book ratio is 1.86 and price to sales ratio is 1579.50.
